We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current WINTW market cap is 51.48k. The company's latest EPS is USD -3.9415 and P/E is -0.08.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 198k | 0 | 0 | 0 | 0 |
| Operating Income | -24.89M | -30.32M | -77.28M | -41.33M | -20.6M |
| Net Income | -27.48M | -32.57M | -67.64M | -39.21M | -20.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 118.98M | 112.89M | 74.79M | 37.95M | 32.41M |
| Total Liabilities | 44.04M | 43.33M | 32.91M | 27.94M | 29.02M |
| Total Equity | 74.94M | 69.55M | 41.88M | 10.01M | 3.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.66M | -25.32M | -23.66M | -19.45M | -13.44M |
| Investing | 13.8M | -291k | -279k | 197k | -15k |
| Financing | 21.77M | 19.96M | 29.36M | 3.08M | 11.6M |
| Market Cap | 51.48k |
| Price to Earnings Ratio | -0.08 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 5.15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (90%) |
| Company Name | Windtree Therapeutics Inc (PK) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.windtreetx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
